Mineralys Therapeutics (MLYS) Assets (2022 - 2026)

Quarterly results put Assets at $652.9 million for Q1 2026, up 83.94% from a year ago — trailing twelve months through Mar 2026 was $652.9 million (up 83.94% YoY), and the annual figure for FY2025 was $661.8 million, up 221.42%.

Mineralys Therapeutics has reported Assets over the past 5 years, most recently at $652.9 million for Q1 2026.

  • Assets reached $652.9 million in Q1 2026 per MLYS's latest filing, down from $661.8 million in the prior quarter.
  • Across five years, Assets topped out at $661.8 million in Q4 2025 and bottomed at $114.4 million in Q4 2022.
  • Median Assets over the past 5 years was $312.5 million (2023), compared with a mean of $356.2 million.
  • The largest annual shift saw Assets decreased 18.17% in 2024 before it surged 221.42% in 2025.
  • Over 5 years, Assets stood at $114.4 million in 2022, then soared by 119.88% to $251.6 million in 2023, then decreased by 18.17% to $205.9 million in 2024, then soared by 221.42% to $661.8 million in 2025, then fell by 1.35% to $652.9 million in 2026.
  • Business Quant data shows Assets for MLYS at $652.9 million in Q1 2026, $661.8 million in Q4 2025, and $599.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - 14.93 Mn
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - 37.37 Mn
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn 1.73 Bn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - 78.88 Mn
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 33.89 Mn
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn 26.48 Bn
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 40.87 Bn
8 Evaxion A 65.12 Bn 65.10 Bn - 23.64 Mn
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn 5.13 Bn
10 Mineralys Therapeutics 2.50 Bn 2.50 Bn - 652.86 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 652.86 Mn
Dec 31, 2025 661.81 Mn
Sep 30, 2025 599.95 Mn
Jun 30, 2025 335.72 Mn
Mar 31, 2025 354.94 Mn
Dec 31, 2024 205.90 Mn
Sep 30, 2024 268.25 Mn
Jun 30, 2024 318.49 Mn
Mar 31, 2024 347.25 Mn
Dec 31, 2023 251.64 Mn
Sep 30, 2023 277.56 Mn
Jun 30, 2023 291.22 Mn
Mar 31, 2023 306.44 Mn
Dec 31, 2022 114.44 Mn